Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies
Pathophysiology · 2018-12 · 25 (4) · 327-333
DOI: 10.1016/j.pathophys.2018.05.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathophysiology, 2018-12. Verfasst von Olusola Olalekan Elekofehinti und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics and Molecular Biology Units, Department of Biochemistry, Federal University of Technology, Akure, Nigeria. Electronic address: ooeleko…. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bioinformatics and Molecular Biology Units, Department of Biochemistry, Federal University of Technology, Akure, Nigeria. Electronic address: ooelekofehinti@futa.edu.ng.
- Bioinformatics and Molecular Biology Units, Department of Biochemistry, Federal University of Technology, Akure, Nigeria.
- Ekiti State University, Ado Ekiti, Nigeria.
- Bioquimica Toxicologia, Departmento de Quimica, CCNE, Universidade Federal de Santa Maria, RS, 97105-900 Brazil.
Zitieren
APA
Elekofehinti, O. O., Ariyo, E. O., Akinjiyan, M. O., Olayeriju, O. S., Lawal, A. O., Adanlawo, I. G., & Rocha, J. B. T. (2018). Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies. Pathophysiology, 25(4), 327-333. https://doi.org/10.1016/j.pathophys.2018.05.003
Vancouver
Elekofehinti OO, Ariyo EO, Akinjiyan MO, Olayeriju OS, Lawal AO, Adanlawo IG, et al. Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies. Pathophysiology. 2018;25(4):327-333. doi:10.1016/j.pathophys.2018.05.003
BibTeX
@article{Elekofehinti2018,
author = {Elekofehinti, Olusola Olalekan and Ariyo, Esther Opeyemi and Akinjiyan, Moses Orimoloye and Olayeriju, Olanrewaju Sam and Lawal, Akeem Olalekan and Adanlawo, Isaac Gbadura and Rocha, Joao Batista Teixeira},
title = {Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies},
journal = {Pathophysiology},
year = {2018},
volume = {25},
number = {4},
pages = {327--333},
doi = {10.1016/j.pathophys.2018.05.003}
}
EUVIMED